Nevro (NVRO) Expected to Beat Earnings Estimates: Should You Buy?

Core Viewpoint - Wall Street anticipates a year-over-year decline in Nevro's earnings due to lower revenues, with a focus on how actual results will compare to estimates impacting stock price [1][2]. Earnings Expectations - Nevro is expected to report a quarterly loss of $0.79 per share, reflecting a significant year-over-year decline of 426.7$104 million, indicating a decrease of 10.5% from the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised 1.19% higher in the last 30 days, suggesting a slight bullish sentiment among analysts [4]. - The Zacks Earnings ESP model indicates that the Most Accurate Estimate is higher than the Zacks Consensus Estimate, resulting in an Earnings ESP of +1.62% [10][11]. Earnings Surprise Prediction - A positive Earnings ESP is a strong indicator of an earnings beat, especially when combined with a Zacks Rank of 1, 2, or 3, which historically leads to a positive surprise nearly 70% of the time [8]. - Nevro's recent surprise history shows it has beaten consensus EPS estimates in the last four quarters, including a +37.80% surprise in the last reported quarter [12][13]. Conclusion - Nevro is positioned as a compelling candidate for an earnings beat, but investors should consider other influencing factors before making investment decisions [16].